Coleen Monroe is from the U.S. but has lived in Italy, South Korea, Chile and now England. Her blog is a chronicle of the adventures of a twentysomething in the 21st century. She just made her first visit to the doctor in England and has a great description of the experience. She didn’t have to […]
Before you head off to your Halloween routine, whether it’s trick-or-treating with your kids or popping Rosemary’s Baby in the DVD player and going to town on a bag of candy, check out these terrifying medical devices to really give you a fright night. The Victorians, of course, had a firm grasp on all things […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
England’s National Health System is the fifth biggest employer in the world. Who is first? The U.S. Department of Defense. The Red Army, Wal-Mart, and McDonald’s make up the rest of the list. Right Honourable Jeremy Hunt M.P. spoke at Datapalooza today and shared that number and several other surprising statistics. The United Kingdom’s Secretary […]
LONDON (Reuters) - BTG's Varisolve treatment for varicose veins has been accepted for review by the U.S. Food and Drug Administration, putting it on track for potential approval and launch during the first half of 2014. The specialty pharmaceutical com...
LONDON (Reuters) - AstraZeneca's experimental rheumatoid arthritis pill fostamatinib produced mixed results in a late-stage clinical trial, the company said on Friday. It achieved a statistically significant improvement in a test assessing signs and sy...
NEW YORK/LONDON (Reuters) - At least three of the world's top drugmakers are bidding for Brazil's Ache Laboratorios Farmaceuticos in an auction that may value the group at more than $5 billion, people familiar with the matter said. Pfizer Inc, Novarti...
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
LONDON (Reuters) - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to the chief executive of GlaxoSmithKline Plc. "It's not unrealisti...
We all get the gist of crowdsourcing challenges that populate sites like InnoCentive and OpenIDEO — here’s a problem, let’s pose it to as many different minds as we can to find the best possible solutions. But a site just launched by four Ph.D. students in England is hoping to spark technology transfer by […]
London-based Cellnovo closes $48 million B round to fund commercialization of the first all mobile diabetes management system, which is drawing comparisons to Apple Inc.'s blockbuster iPhone and iPod platforms.
GlaxoSmithKline's Avandia problems are resulting in the company setting aside $3.4 billion to pay for legal costs related to its former diabetes drug, which has been linked to greater cardiovascular risks. Though the drug is now scarce in the European and U.S. markets thanks to greater regulatory scrutiny, GSK faces mounting expenses as Avandia legal claims continue to be filed.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Highlights of the important and the interesting from the world of healthcare: Is Genzyme on the block? A report that GlaxoSmithKline “casually requested” that Genzyme let it know if the latter ever puts itself up for sale has created a bit of a buzz, even if it’s unlikely GSK would be interested in pulling the […]